|
Contact
|
Newsletter
|
Sitemap
|
Deutsch
»
Bayer Group
Home
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroup Management Boards
Supervisory Board
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
TV Service
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Jobs and Career
Foundations
Sports
Culture
Topics
Europe
|
1 - 7
|
Friday - January 27, 2012
CEO Sandra Peterson at the 2012 World Economic Forum in Davos:
Bayer CropScience committed to the “New Vision for Agriculture” Initiative
Active role in global initiative to transform agriculture / Innovative, multi-stakeholder partnerships key to develop the agricultural sector
» more
Tuesday - January 24, 2012
Bayer CropScience at the International Green Week, Berlin, Germany:
Bayer affirms commitment to safeguard food security through innovation and sustainable agriculture
» more
Monday - December 19, 2011
For use outside the US and UK only
Bayer’s Xarelto® Approved in the EU for the Prevention of Stroke in Patients with AF and in the Treatment of DVT
In stroke prevention in AF, Xarelto is the only oral anticoagulant offering patients a once-daily, highly effective therapy without need for routine coagulation monitoring / For the treatment of DVT and the prevention of recurrent DVT and PE, Xarelto is the first oral anticoagulant to offer patients both efficacy and the convenience of a single-drug solution, without the need for injections or monitoring / Xarelto is now approved in the EU across three indications in the area of venous and arterial thromboembolism (VAT)
» more
Friday - November 11, 2011
EUR 4 million investment in Germany:
Bayer CropScience subsidiary HILD opens new seed technology facility for vegetables and herbs
» more
Monday - August 8, 2011
Bayer CropScience receives UK approval for pioneering seed treatment product:
New potato-enhancing product Emesto™ registered in first market
» more
Monday - June 27, 2011
Cooperation with leading European seed company:
Bayer CropScience and RAGT Semences sign licensing and cooperation agreement for the improvement of wheat
» more
Wednesday - April 27, 2011
Bayer CropScience at the International Seed Federation Congress 2011 in Belfast:
Sustainable solutions for higher yields and more added value
» more
|
1 - 7
|
Copyright @ Bayer AG
General Conditions of Use
-
Privacy Statement
-
Imprint
Print page
Search
Advanced Search
Publications
Stockholders' Newsletter
Sustainable Development Report
Annual Report
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Tuesday, February 28, 2012
Financial News Conference Full Year 2011
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)